709-1217

completed

Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
709 (USA) · Dr. Novak
consented 2013-03-04

AEs

Serious

Dropout signal

–

Adverse events

mild assessed

Mild APPLICATION SITE DERMATITIS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-03-26 (study day 23.0); relationship: PROBABLE

moderate assessed

Moderate APPLICATION SITE DERMATITIS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-03-26 (study day 23.0); relationship: PROBABLE

moderate assessed

Moderate APPLICATION SITE DERMATITIS — outcome: RECOVERED/RESOLVED; onset 2013-03-26 (study day 23.0); relationship: PROBABLE

mild assessed

Mild COUGH — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-03-20 (study day 17.0); relationship: NONE

moderate assessed

Moderate DIZZINESS — outcome: RECOVERED/RESOLVED; onset 2013-03-06 (study day 3.0); relationship: POSSIBLE

mild assessed

Mild DIZZINESS — outcome: RECOVERED/RESOLVED; onset 2013-03-27 (study day 24.0); relationship: POSSIBLE

mild assessed

Mild DIZZINESS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-04-01 (study day 29.0); relationship: POSSIBLE

mild assessed

Mild DIZZINESS — outcome: RECOVERED/RESOLVED; onset 2013-04-01 (study day 29.0); relationship: POSSIBLE

mild assessed

Mild ELECTROCARDIOGRAM T WAVE INVERSION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-03-30 (study day 27.0); relationship: NONE

mild assessed

Mild HEADACHE — outcome: RECOVERED/RESOLVED; onset 2013-05-17 (study day 75.0); relationship: REMOTE

moderate assessed

Moderate PRURITUS — outcome: RECOVERED/RESOLVED; onset 2013-05-27 (study day 85.0); relationship: PROBABLE

Data queries

No data queries.